Clinical Trials Logo
  1. Home
  2. Major Depressive Disorders
  3. NCT02829671

Loneliness and Occurrence of Suicide Attempts and Suicidal Ideas — SOLSTIS  

Major Depressive Disorders Clinical Trial

Official title:
Study of Loneliness as Predictive Factor for Suicidal Behavior

Clinical Trial Summary

Suicide is a major health problem that causes annually a million death worldwide. Loneliness is known to be associated with suicidal ideation in minors and to be related with suicidal risk in elderly people. However little is known about this association in a middle-aged population. Loneliness is a modifiable factor with suitable psychotherapeutic measures, it is essential to improve the scientific and medical knowledge about the link between this feeling and suicide risk in a population of depressed patients in middle age. The main objective is the study of the relationship between loneliness and the occurrence of suicidal behavior (SB) in major depressed adult population over 12 months. The secondary objectives are: - Identification of risk factors (clinical, neuropsychological and biological) of the occurrence of SB within a clinical population and their interaction; - Identification of predictive factors (clinical, neuropsychological, biological) therapeutic response to antidepressant in the context of depression.

Clinical Trial Description

This project is based on clinical, neuropsychological and biological data routinely collected in the Department of Emergency Psychiatry and Post Acute Care. This is a one year follow-up prospective study. Over three years, 600 depressed patients will be recruited. - First visit (inclusion): clinical, biological and neuropsychological assessment - Follow up visits (3, 6 and 12 months): clinical assessment only ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02829671
Study type Interventional
Source University Hospital, Montpellier
Contact
Status Completed
Phase N/A
Start date October 11, 2016
Completion date June 24, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02972398 - N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders N/A
Completed NCT00855530 - Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder Phase 3
Completed NCT00825019 - Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine Phase 3
Recruiting NCT02681822 - Multi-center Imaging Genetics Studies in China
Completed NCT00825058 - Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine Phase 3
Recruiting NCT04497493 - Efficacy of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Major Depressive Disorder N/A
Completed NCT01347138 - Health Care Management for the Elderly in Community Through Screening N/A
Completed NCT01377896 - The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours N/A
Completed NCT02449447 - Blended Depression Therapy: Cognitive Behaviour Therapy Face-to-face and Via Internet N/A
Completed NCT06239740 - Effects of Electroacupuncture on Cognitive Symptoms in Major Depressive Disorder N/A
Not yet recruiting NCT02942251 - Relapse Predicting Model for First Episode Depression N/A
Recruiting NCT02590185 - MetAbolism vaRiability of VEnLafaxine N/A